217730 — Kang Stem Biotech Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Market Cap
KR₩145bn
Enterprise Value
KR₩123bn
Revenue
KR₩13bn

Annual balance sheet for Kang Stem Biotech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	47,712	37,633	56,568	36,669	37,356
Net Total Accounts Receivable
Net Total Receivables	2,212	1,657	2,831	3,672	4,266
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	55,408	44,751	65,355	45,907	47,366
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	34,978	34,794	34,126	31,265	29,572
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	113,644	82,505	103,148	80,592	81,253
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	20,599	12,206	22,473	19,709	24,199
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	42,923	30,886	35,075	31,222	33,242
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	70,721	51,620	68,073	49,370	48,012
Total Liabilities & Shareholders' Equity	113,644	82,505	103,148	80,592	81,253
Total Common Shares Outstanding
Total Preferred Shares Outstanding